CERS — CERUS CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1020214 ·
Last close
$2.45
Market Cap
$493.74M
52W High
$3.47
52W Low
$1.38
ADV30
1,713,890
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 57,441,000 | 29,532,000 | -1,858,000 | -2,940,000 | 205,187,000 | 17,980,000 | 134,472,000 |
| Mar 2026 | 53,661,000 | 27,894,000 | -354,000 | -1,640,000 | 222,908,000 | 27,850,000 | 154,622,000 |
| Dec 2025 | 57,751,000 | 29,749,000 | -641,000 | -2,184,000 | 221,859,000 | 19,961,000 | 156,894,000 |
| Sep 2025 | 52,698,000 | 28,140,000 | 1,236,000 | -19,000 | 215,185,000 | 15,670,000 | 152,981,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,417,000
Investing CF
$18,839,000
Financing CF
$-19,558,000
CapEx
$-4,246,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.03
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,085,735,000
Inventory
$65,813,000
Receivables
$30,975,000
ST Investments
$38,284,000
EBIT TTM
$1,225,000
Pretax Income TTM
$-6,444,000
Interest Exp TTM
$7,669,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$221,551,008
EBITDA
$66,000
Free Cash Flow
$875,250
Enterprise Value
$523,023,008
Total Cash
$56,264,000
Total Debt
$76,799,000
Shares Out
201,524,898
Trailing EPS
$-0.03
Book Value
$0.35
ROE
-10.8%
ROA
-0.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 206,133,000 | -8,681,000 | -15,627,000 | 221,859,000 | 156,894,000 | 64,224,000 | 4,837,000 |
| Dec 2024 | 180,270,000 | -14,225,000 | -20,918,000 | 200,917,000 | 144,021,000 | 56,145,000 | 11,359,000 |
| Dec 2023 | 156,367,000 | -26,325,000 | -37,489,000 | 197,748,000 | 144,304,000 | 52,650,000 | -43,168,000 |
| Dec 2022 | 162,048,000 | -34,081,000 | -42,779,000 | 218,092,000 | 149,530,000 | 67,610,000 | -25,615,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.01
Max Pain — expiry 2026-12-18
max pain strike: $1.50 · spot: $2.45 · call oi: 2,173 · put oi: 356
Expected Move to 2026-12-18:
±$1.15
(46.94%) —
implied range
$1.30 –
$3.60
· ATM straddle on $2.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NPCE | NeuroPace Inc | $485.69M | $14.15 | — |
| SGHT | Sight Sciences, Inc. | $510.67M | $9.27 | — |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $516.93M | $22.82 | — |
| CLPT | ClearPoint Neuro, Inc. | $467.02M | $15.31 | — |
| BWAY | Brainsway Ltd. | $532.76M | $13.25 | — |
News headlines (Yahoo Finance, 1h cache)
Cerus Q2 Earnings Call Highlights
2026-07-30 22:04 · Yahoo
Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
2026-07-16 20:01 · Yahoo
Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress
2026-06-17 12:30 · Yahoo
Cerus Corporation Closes New Debt Facility of Up to $110 Million
2026-06-08 12:30 · Yahoo
Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG
2026-05-23 12:16 · Yahoo
Cerebras IPO in focus as Nvidia earnings loom
2026-05-15 15:06 · Yahoo
Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
2026-05-01 07:17 · Yahoo
Cerus Q1 Earnings Call Highlights
2026-04-30 22:16 · Yahoo
Cerus Corporation Q1 2026 Earnings Call Summary
2026-05-01 12:30 · Yahoo
Cerus (CERS) Q1 2026 Earnings Transcript
2026-04-30 23:26 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.